Preclinical Studies of Mesenchymal Stem Cell (MSC) Administration in Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis.
In the last two decades, mesenchymal stem cells (MSCs) have been pre-clinically utilized in the treatment of a variety of kinds of diseases including chronic obstructive pulmonary disease (COPD). The aim of the current study was to systematically review and conduct a meta-analysis on the published p...
Main Authors: | Xiangde Liu, Qiuhong Fang, Huijung Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4900582?pdf=render |
Similar Items
-
Mesenchymal stem cell therapy in pulmonary fibrosis: a meta-analysis of preclinical studies
by: Deng-Yuan Li, et al.
Published: (2021-08-01) -
Mesenchymal Stem Cell Administration in Patients with Chronic Obstructive Pulmonary Disease: State of the Science
by: Shih-Lung Cheng, et al.
Published: (2017-01-01) -
Mesenchymal stem cell therapy for paraquat poisoning: A systematic review and meta-analysis of preclinical studies.
by: Fang He, et al.
Published: (2018-01-01) -
Immunogenicity of allogeneic mouse mesenchymal stem cells (MSC)
by: Mukonoweshuro, Blessing
Published: (2012) -
Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients
by: Rui-Juan Cheng, et al.
Published: (2019-11-01)